Sulforaphane and Epigallocatechin Gallate Restore Estrogen Receptor Expression by Modulating Epigenetic Events in the Breast Cancer Cell Line MDA-MB-231: A Systematic Review and Meta-Analysis

Sulforaphane Alone and in Combination with Clofarabine Epigenetically Regulates the Expression of DNA Methylation-Silenced Tumour Suppressor Genes in Human Breast Cancer Cells

(2015) Katarzyna Lubecka-Pietruszewska et al.   Journal of Nutrigenetics and Nutrigenomics

Breast Cancer: Epidemiology and Etiology

(2014) ZiQi Tao et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators

(2014) Moonmoon Deb et al.   TUMOR BIOLOGY

Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation

(2013) Huaping Chen et al.   EXPERIMENTAL CELL RESEARCH

Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane

(2013) Huaping Chen et al.   Journal of Oncology

Molecular medicine and the development of cancer chemopreventive agents

(2012) Alberto Izzotti   Annals of the New York Academy of Sciences

Sulforaphane Induction of p21Cip1Cyclin-dependent Kinase Inhibitor Expression Requires p53 and Sp1 Transcription Factors and Is p53-dependent

(2012) Yap Ching Chew et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis

(2012) Alberto Izzotti et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications

(2012) Syed M. Meeran et al.   PLoS One

Breast cancer statistics, 2011

(2011) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Novel Prodrug of Epigallocatechin-3-gallate: Differential Epigenetic hTERT Repression in Human Breast Cancer Cells

(2011) S. M. Meeran et al.   Cancer Prevention Research

Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods

(2011) Jan O. Friedrich et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

From Waddington’s epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research

(2011) Supratim Choudhuri   TOXICOLOGY MECHANISMS AND METHODS

Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines

(2010) Syed M. Meeran et al.   PLoS One

Graphical displays for meta-analysis: An overview with suggestions for practice

(2010) Judith Anzures-Cabrera et al.   Research Synthesis Methods

Epigenetics in cancer

(2009) S. Sharma et al.   CARCINOGENESIS

The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study

(2008) Jan O Friedrich et al.   BMC Medical Research Methodology